LicianPro

DMAC holders · CITADEL ADVISORS LLC 13F · DMAC stock

CITADEL ADVISORS LLC DiaMedica Therapeutics Inc (DMAC) 13F holding

CITADEL ADVISORS LLC reported 145,724 DMAC shares valued at $986.6K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest DMAC 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the DMAC holders table.

DMAC reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-31145,724$986.6KCOM NEW
2025-12-31110,737$881.5KCOM NEW
2025-09-3069,352$476.4KCOM NEW

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.